strontium ranelate

Chemical data

Formula

C12H6N2O8SSr2

Molecular weight

513.5 g/mol

IUPAC name

distrontium;5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate

SMILES

C(C1=C(SC(=C1C#N)N(CC(=O)[O-])CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Sr+2].[Sr+2]

InChIKey

XXUZFRDUEGQHOV-UHFFFAOYSA-J

Polar surface area

216 Ų

H-bond donors

0

H-bond acceptors

11

Formal charge

0

via PubChem

Drug data · ChEMBL

Max clinical phase

Approved

Molecule type

Small molecule

First approval

2004

Indications

bone disease, postmenopausal osteoporosis

via ChEMBL · EBI

• Strontium ranelate in post-menopausal osteoporosis.Endokrynologia Polska · 2011
• Strontium ranelate, a promising disease modifying osteoarthritis drug.Expert opinion on investigational drugs · 2017
• Strontium ranelate: a novel mode of action optimizing bone formation and resorption.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2005
• Strontium ranelate for osteoporosis?Drug and therapeutics bulletin · 2006
• Strontium ranelate: a physiological approach for optimizing bone formation and resorption.Bone · 2006

via PubMed

Wikidata facts

Subclass of

chemical compound

Mass

513.79571

Has use

medication

via Wikidata · CC0